Davinci- what a scam

Discussion in 'Intuitive Surgical Patient Discussions' started by Anonymous, Jun 22, 2012 at 7:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Please cite where this study was “discredited.”
     

  2. anonymous

    anonymous Guest

    Hats off to everyone who has spread the word that the DaVinci robot kills and injures innocent people.

    The word is out - it is a dangerous and gimmicky remote controlled laparoscopic surgery still in beta stages based on all the patent redesign applications.

    “Intuitive Surgical Inc. (ISRG) was down nearly 4% in premarket trading after posting disappointing fourth-quarter earnings.”
     
  3. anonymous

    anonymous Guest

  4. anonymous

    anonymous Guest

  5. anonymous

    anonymous Guest

  6. anonymous

    anonymous Guest

    now the ever so never accurate Motley Fool states this in a podcast:

    Hill: I thought they just sold the systems. They get paid based on the number of procedures?

    Bush: Yeah.

    This is obviously not referring to reusable and/or disposable instruments, support or service.

    Someone please explain this!!!
     
  7. anonymous

    anonymous Guest

    Fourth quarter 2018 GAAP income from operations increased to $332 million, compared with $329 million in the fourth quarter of 2017. Fourth quarter 2018 non-GAAP* income from operations increased to $412 million, compared with $386 million in the fourth quarter of 2017.

    What’s up with your employers operations costs increasing? Trying to bandaid a broken robot? Poor outcomes and litigation expenses are a result of poor operations and manufacturing processes which directly results in a defectively designed and manufactured piece of shit without any twinkle of the machine learning technology your competition is incorporating.

    Remember - poor operations and manufacturing results in injuries and litigation - let’s not forget all the important data brought to our attention in the Pohly case...

    https://safepatientadvocate.com/wp-content/uploads/2017/03/2017-03-13-066-Redacted-Pl-MPSJ-Memorandum.pdf
     
  8. anonymous

    anonymous Guest

    the davinci robot kills people.
     
  9. anonymous

    anonymous Guest

    So does ignorance
     
  10. anonymous

    anonymous Guest

    Both such true statements! My ignorance around the dangers of the DaVinci robot and agreement to allow it to be used in my surgery almost killed me. FYI - my DaVinci robotic surgery performed at the worlds #1 clinic by one of their top oncology surgeons....

    Please review the most recent submissions to the fda by Intuitive Surgical. 5 adverse event types submitted this month by Intuitive Surgical with the event type “death.”

    Also, trending again is the issue with the tip cover accessories and the corresponding micro cracks and thermal leaks causing the omnipresent charring and burning patients.

    “It was reported that during a da vinci-assisted radical hysterectomy procedure, electrical energy burned through a monopolar curved scissors (mcs) tip cover accessory that was installed on a mcs instrument. As a result, the patient sustained an injury through the iliac artery. The case was reportedly converted to open surgery. On (b)(4) 2019, The site¿s robotics coordinator claimed that electrical energy ¿escaped¿ through the mcs tip cover accessory. The surgical staff initially attempted to repair the vessel injury using the da vinci surgical system. However, the case was reportedly converted to open surgery to repair the vessel. The csa indicated that the last time he had spoken to the customer, the site¿s risk management department had the mcs instrument and/or mcs tip cover accessory.”
     
  11. anonymous

    anonymous Guest

    I wonder how much Intuitive Surgical is going to pay for that tip cover - one way or another $$$ ;)
     
  12. anonymous

    anonymous Guest

    News > Medscape Medical News > Oncology News
    Robotic Mastectomy in US: Starts, Draws Fire, Stops
    Potential 'Disaster' or Evolutionary 'Next Step'?


    Nick Mulcahy

    February 07, 2019

    Robotic mastectomy for invasive breast cancer was performed for the first time in the United States last year, but the move toward this surgical approach ground to a halt soon afterward.

    The first such operation was performed in September 2018 by Stephen Chagares, MD, at the Monmouth County Medical Center in Long Branch, New Jersey.

    Chagares "docked" the robot well off to the side of the breast. The resulting incision left a scar hidden under the armpit. The robotic nipple-sparing mastectomy involved total removal of breast tissue, followed immediately by implant placement.

    The patient, Yvonne Zucco, was very satisfied, according to an article published in October in the Asbury Park Press.


    "I don't even look like I had anything done," said Zucco, aged 56.

    "To be able to wake from surgery, look down, not see any visible scars and have my nipples and areolas intact with implants in is amazing," she said in a press release about the surgery.

    "Robotic mastectomy, with immediate reconstruction, opens the door to a new era of mastectomy and a new outlook for patients who are candidates," commented Chagares.

    However, robotic mastectomy was soon stopped by the community-based center, which "decided to suspend the procedure until further review."

    Months later, there has been no change in policy at Monmouth Medical Center since it issued its brief original statement, a spokesperson told Medscape Medical News this week.

    What happened?

    The answer appears to be that Hooman Noorchashm, MD, PhD, a Philadelphia-based surgeon turned patient advocate, became involved and raised questions about the safety and appropriateness of using the da Vinci robot (Intuitive Surgical Inc), which is not approved for mastectomy.

    "Certainly, [robotic mastectomy] is not ready for prime time or widespread application in community hospital settings in the United States," Noorchashm commented in an email to journalists about the procedure and the case at Monmouth Medical Center.


    However, this past week, Noorchashm upped his rhetoric, telling Medscape Medical News that the robotic mastectomy scenario in North Jersey — and events unfolding elsewhere — have the potential makings of the beginning of a public health "disaster."
     
  13. anonymous

    anonymous Guest

    News > Medscape Medical News > Oncology News
    Robotic Mastectomy in US: Starts, Draws Fire, Stops
    Potential 'Disaster' or Evolutionary 'Next Step'?


    Nick Mulcahy

    February 07, 2019

    Robotic mastectomy for invasive breast cancer was performed for the first time in the United States last year, but the move toward this surgical approach ground to a halt soon afterward.

    The first such operation was performed in September 2018 by Stephen Chagares, MD, at the Monmouth County Medical Center in Long Branch, New Jersey.

    Chagares "docked" the robot well off to the side of the breast. The resulting incision left a scar hidden under the armpit. The robotic nipple-sparing mastectomy involved total removal of breast tissue, followed immediately by implant placement.

    The patient, Yvonne Zucco, was very satisfied, according to an article published in October in the Asbury Park Press.


    "I don't even look like I had anything done," said Zucco, aged 56.

    "To be able to wake from surgery, look down, not see any visible scars and have my nipples and areolas intact with implants in is amazing," she said in a press release about the surgery.

    "Robotic mastectomy, with immediate reconstruction, opens the door to a new era of mastectomy and a new outlook for patients who are candidates," commented Chagares.

    However, robotic mastectomy was soon stopped by the community-based center, which "decided to suspend the procedure until further review."

    Months later, there has been no change in policy at Monmouth Medical Center since it issued its brief original statement, a spokesperson told Medscape Medical News this week.

    What happened?

    The answer appears to be that Hooman Noorchashm, MD, PhD, a Philadelphia-based surgeon turned patient advocate, became involved and raised questions about the safety and appropriateness of using the da Vinci robot (Intuitive Surgical Inc), which is not approved for mastectomy.

    "Certainly, [robotic mastectomy] is not ready for prime time or widespread application in community hospital settings in the United States," Noorchashm commented in an email to journalists about the procedure and the case at Monmouth Medical Center.


    However, this past week, Noorchashm upped his rhetoric, telling Medscape Medical News that the robotic mastectomy scenario in North Jersey — and events unfolding elsewhere — have the potential makings of the beginning of a public health "disaster."
     
  14. anonymous

    anonymous Guest

    J&J to Acquire Robotic-Surgery Firm Auris for $3.4 Billion

    “Moll will join J&J after the deal closes, which is expected by the end of the second quarter. He was the founder of Intuitive Surgical Inc., a pioneer in robotic laparoscopic surgery tools now valued at roughly $60 billion. Intuitive’s shares fell 2.1 percent to $528.34 at 9:32 a.m. in New York.”

    https://www.industryweek.com/leadership/jj-acquire-robotic-surgery-firm-auris-34-billion
     
  15. anonymous

    anonymous Guest

    This is wonderful news!! No more monopoly on robotic surgery will force Intuitive to actually understand “innovation” and design based on safety and real metrics instead of hanging its hat on research studies by “doctors” paid by Intuitive themselves.

    Verb Surgical incorporates data analytics and machine learning into their robotics, and the new acquisition of Auris will definitely move things along to ideally show ISI what surgery looks like without instruments breaking into patients never to be found, burning, arcing, injuring and killing. Currently the DaVinci has no technology to learn from its mistakes...and apparently its manufacturer, Intuitive Surgical, doesn’t either.
     
  16. anonymous

    anonymous Guest

    “In addition, Auris Health technology is intended to accelerate J&J’s strategy for the continuum of surgical approaches such as open, laparoscopic, robotic and endoluminal procedures.“
     
  17. anonymous

    anonymous Guest

  18. anonymous

    anonymous Guest

     
  19. anonymous

    anonymous Guest

    DWAS IS TOGETHER AGAIN WOO HOO!!